Application no. and date | 18821458.9 (espacenet) (Federated) (European Patent Register), 20180622 | Patent/reg. no. and date | DK/EP 3641888, 20231011 | Publication date | 20200429 | Priority no. and date | US 201762523901 P, 20170623 | EP pub. no. and date |
EP 3641888 20200429 | Effective date | | Applicant/owner | Kedrion Biopharma Inc., 400 Kelby Street, 11th Floor,
Fort Lee, NJ 07024, US | Applicant ref. no. | V2312-022-DK | Inventor | GAGNON, Lyne, 1973 De la Victoire Street
Laval, Quebec H7M 3E5, CA, LAURIN, Pierre, 2250Chemin Sunset
Ville Mont-Royal, Quebec H3R 2Y6, CA, GROUIX, Brigitte, 2505 rue Sauriol est
Montréal, Québec H2B 1H2, CA | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | Opponent | | IPC Class | A61K 38/48 (2006.01) , A61P 17/02 (2006.01) , A61P 29/00 (2006.01) , A61P 3/00 (2006.01) , A61P 7/02 (2006.01) , A61P 9/00 (2006.01) | Title | PLASMINOGENBEHANDLING AF TILSTANDE FORBUNDET MED PAI-1-OVEREKSPRESSION | Int. application no. | IB2018000655 | Int. publication no. | WO2018234861 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|